Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Visceral Medicine

• Publication date

  2017-02-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000454693PMID 28612017PMCID PMC5465659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential

  2018cited by this paper
• Updated long‐term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy

  2016cited by this paper
• Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies

  2016cited by this paper
• Prospective Phase II Trial of Combination Hepatic Artery and Systemic Chemotherapy for Unresectable Colorectal Liver Metastases: Long-Term Results and Curative Potential

  2016cited by this paper
• Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases

  2016cited by this paper
• Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.

  2015cited by this paper
• Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.

  2015cited by this paper
• Phase II study on hepatic arterial infusion chemotherapy using percutaneous catheter placement techniques for liver metastases from colorectal cancer (JFMC28 study)

  2015cited by this paper
• Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

  2015cited by this paper
• Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer

  2014cited by this paper
• KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases

  2014cited by this paper
• Hepatic resection for colorectal metastases

  2014cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer

  2013cited by this paper
• Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

  2013cited by this paper
• Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Hepatic Arterial Infusion with Irinotecan, Oxaliplatin, and Floxuridine plus Systemic Chemotherapy as First-Line Treatment of Unresectable Liver Metastases from Colorectal Cancer

  2012cited by this paper
• Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer

  2011cited by this paper
• Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.

  2010cited by this paper
• Regional hepatic chemotherapies in treatment of colorectal cancer metastases to the liver.

  2010cited by this paper
• Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

  2009cited by this paper
• Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.

  2009cited by this paper
• Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.

  2009cited by this paper
• Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

  2008cited by this paper
• Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

  2008cited by this paper
• Interventional Oncology: Clinical Management of Patients with Colorectal Liver Metastasis Using Hepatic Arterial Infusion

  2008cited by this paper
• Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.

  2008cited by this paper
• Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer: A Multifactorial Model of 929 Patients

  2008cited by this paper
• Improved Long-Term Outcome of Surgery for Advanced Colorectal Liver Metastases: Reasons and Implications for Management on the Basis of a Severity Score

  2007cited by this paper
• Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases

  2007cited by this paper
• Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis.

  2007cited by this paper
• Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.

  2007cited by this paper
• Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure

  2007cited by this paper
• Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study.

  2006cited by this paper
• Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.

  2005cited by this paper
• Hepatic arterial infusion after liver resection.

  2005cited by this paper
• Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.

  2005cited by this paper
• Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

  2005cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

  2004cited by this paper
• Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model

  2004cited by this paper
• Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver.

  2004cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• Patterns of failure following curative resection of colorectal liver metastases.

  2003cited by this paper
• Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.

  2003cited by this paper
• An update on hepatic arterial infusion chemotherapy for colorectal cancer.

  2003cited by this paper
• Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.

  2003cited by this paper
• Abstracts reprinted from Journal of Clinical Oncology

  2002cited by this paper
• Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study.

  2002cited by this paper
• Repeat hepatectomy for colorectal liver metastases: A worthwhile operation?

  2001cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

  2001cited by this paper
• Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases

  2001cited by this paper
• Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal.

  2001cited by this paper
• Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.

  2001cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000cited by this paper
• Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

  1999cited by this paper
• Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

  1999cited by this paper
• Hepatic resection for colorectal metastases

  1999cited by this paper
• Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.

  1996cited by this paper
• Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity.

  1996cited by this paper
• Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

  1996cited by this paper
• Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

  1996cited by this paper
• A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer

  1992cited by this paper
• Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.

  1991cited by this paper
• Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history

  1990cited by this paper
• A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5‐fluoro‐2‐deoxyuridine

  1985cited by this paper
• Pharmacologic rationale for regional drug delivery.

  1984cited by this paper
• Clinical pharmacology of hepatic arterial chemotherapy.

  1983cited by this paper
• Clinical pharmacology of hepatic arterial chemotherapy.

  1983cited by this paper
• Totally implanted drug delivery system for hepatic arterial chemotherapy.

  1981cited by this paper
• A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

  1978cited by this paper
• [Treatment of liver metastases].

  1978cited by this paper
• The blood supply of neoplasms in the liver.

  1954cited by this paper

• Primary tumor resection improves survival in colon cancer patients with unresectable liver only metastases

  2025cites this paper
• Assessment of non-tumor liver parenchyma damage in advanced gastric cancer treatment with transarterial infusion chemotherapy: a study using imaging and hepatic injury indicators

  2025cites this paper
• Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study – (NCT05103020) – study protocol

  2023cites this paper
• Outcomes of Patients With Colorectal Liver Metastasis in the Developing World: Is Liver Transplantation for Unresectable Liver Metastasis, the Next Logical Step?

  2023cites this paper
• Imaging of the hepatic arterial infusion pump: Primer for radiologists.

  2023cites this paper
• Hepatic arterial infusion chemotherapy in hepatocellular carcinoma: A bibliometric and knowledge-map analysis

  2023cites this paper
• Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study

  2022cites this paper
• Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program

  2022cites this paper
• Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study

  2021cites this paper
• Progress toward improving outcomes in patients with cholangiocarcinoma

  2021cites this paper
• Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study

  2021cites this paper
• The evolution of interventional oncology in the 21st century.

  2020cites this paper
• Tumor Biology and Multidisciplinary Strategies of Oligometastasis in Gastrointestinal Cancers.

  2020cites this paper
• Colorectal Liver Metastasis: Current Concepts

  2020cites this paper
• Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review

  2020cites this paper
• A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks.

  2020cites this paper
• Survival Outcomes in Unresectable Metastatic Rectal Cancer Patients after both Primary Site Resection and Chemoradiotherapy: A Population-based Study

  2020cites this paper
• Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review

  2020cites this paper
• Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review

  2020cites this paper
• Intraarterial chemotherapy in treatment of unresectable colorectal liver metastases refractory to systemic chemotherapy

  2019cites this paper
• Aberrant arc between the common hepatic artery and a replaced right hepatic artery resulting in misperfusion in a patient with a hepatic arterial infusion pump

  2019cites this paper
• Chapter 4 Local Treatment Options for Unresectable Liver Metastases in Colorectal Cancer

  2019cites this paper
• Dietary glycine decreases both tumor volume and vascularization in a combined colorectal liver metastasis and chemotherapy model

  2019influential citation
• Local Therapy Modalities in Management of Colorectal Cancer Liver Metastasis

  2019cites this paper
• Hepatic Artery Infusion Therapy for Colorectal Cancer Liver Metastases

  2018cites this paper
• Minimally Invasive Treatment of a Bronchobiliary Fistula that Developed Secondary to Chemotherapy-induced Stricturing

  2018cites this paper
• Impact of liver tumor percutaneous radiofrequency ablation on circulating tumor cells

  2018cites this paper
• Local Treatment Options for Unresectable Liver Metastases in Colorectal Cancer

  2018cites this paper
• Oligometastases of Gastrointestinal Cancer Origin

  2017cites this paper
• (18-Crown-6)potassium(I) Trichlorido[28-acetyl-3-(tris-(hydroxylmethyl)amino-ethane)betulinic ester-κN]platinum(II): Synthesis and In Vitro Antitumor Activity

  2017cites this paper